Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clara Chen

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Pancreas|July 31, 2023
Endoscopic Ultrasound Guided Shear Wave Elastography Is Safe With High Feasibility and Reproducibility When Used in the Pancreas: Findings From a Prospective CohortYazan Abboud, Katherine Kim, Jamil S Samaan, et al.
The New England Journal of Medicine|July 17, 2009
Disclosure of APOE genotype for risk of Alzheimer's diseaseRobert C Green, J Scott Roberts, L Adrienne Cupples, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancerPhilip M Arlen, James L Gulley, Catherine Parker, et al.
Cancer Biology & Therapy|September 3, 2005
A phase II study of perifosine in androgen independent prostate cancerEdwin M Posadas, James Gulley, Philip M Arlen, et al.
The Journal of Urology|August 21, 2007
Clinical safety of a viral vector based prostate cancer vaccine strategyPhilip M Arlen, Lisa Skarupa, Mary Pazdur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2025
Erratum: Phase II Study of <sup>177</sup>Lu-DOTATATE for Progressive Metastatic Pheochromocytomas and Paragangliomas: Interim Analysis of Efficacy, Safety, and BiomarkersFrank I Lin, Jaydira Del Rivero, Jorge A Carrasquillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2025
Phase II Study of <sup>177</sup>Lu-DOTATATE for Progressive Metastatic Pheochromocytomas and Paragangliomas: Interim Analysis of Efficacy, Safety, and BiomarkersFrank I Lin, Jaydira Del Rivero, Jorge A Carrasquillo, et al.
International Psychogeriatrics|April 17, 2023
Cost consequence analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2)Krista L Lanctôt, Clara Chen, Ethan Mah, et al.
Cancer Immunology, Immunotherapy : CII|November 6, 2009
Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancerJames L Gulley, Philip M Arlen, Ravi A Madan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2024
First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 TrialYelena Y Janjigian, Jaffer A Ajani, Markus Moehler, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Pancreas|July 31, 2023
Endoscopic Ultrasound Guided Shear Wave Elastography Is Safe With High Feasibility and Reproducibility When Used in the Pancreas: Findings From a Prospective CohortYazan Abboud, Katherine Kim, Jamil S Samaan, et al.
The New England Journal of Medicine|July 17, 2009
Disclosure of APOE genotype for risk of Alzheimer's diseaseRobert C Green, J Scott Roberts, L Adrienne Cupples, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancerPhilip M Arlen, James L Gulley, Catherine Parker, et al.
Cancer Biology & Therapy|September 3, 2005
A phase II study of perifosine in androgen independent prostate cancerEdwin M Posadas, James Gulley, Philip M Arlen, et al.
The Journal of Urology|August 21, 2007
Clinical safety of a viral vector based prostate cancer vaccine strategyPhilip M Arlen, Lisa Skarupa, Mary Pazdur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2025
Erratum: Phase II Study of <sup>177</sup>Lu-DOTATATE for Progressive Metastatic Pheochromocytomas and Paragangliomas: Interim Analysis of Efficacy, Safety, and BiomarkersFrank I Lin, Jaydira Del Rivero, Jorge A Carrasquillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2025
Phase II Study of <sup>177</sup>Lu-DOTATATE for Progressive Metastatic Pheochromocytomas and Paragangliomas: Interim Analysis of Efficacy, Safety, and BiomarkersFrank I Lin, Jaydira Del Rivero, Jorge A Carrasquillo, et al.
International Psychogeriatrics|April 17, 2023
Cost consequence analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2)Krista L Lanctôt, Clara Chen, Ethan Mah, et al.
Cancer Immunology, Immunotherapy : CII|November 6, 2009
Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancerJames L Gulley, Philip M Arlen, Ravi A Madan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2024
First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 TrialYelena Y Janjigian, Jaffer A Ajani, Markus Moehler, et al.
Pageof 6